BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Federal Trade Commission
Dow
Moodys
Baxter
Covington
McKinsey
Boehringer Ingelheim
Medtronic

Generated: January 20, 2018

DrugPatentWatch Database Preview

OXACILLIN SODIUM - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxacillin sodium and what is the scope of oxacillin sodium patent protection?

Oxacillin sodium
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Ani Pharms Inc, Apothecon, Teva, Baxter Hlthcare, Aurobindo Pharma Ltd, Elkins Sinn, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Renaissance Ssa Llc, Sagent Pharms, Sandoz, Watson Labs Inc, and Wockhardt Bio Ag, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for oxacillin sodium. Six suppliers are listed for this compound.
Pharmacology for OXACILLIN SODIUM
Medical Subject Heading (MeSH) Categories for OXACILLIN SODIUM

US Patents and Regulatory Information for OXACILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062711-006 Feb 3, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Istituto Bio Ita Spa OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062798-003 Dec 11, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 091246-001 Mar 30, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline BACTOCILL oxacillin sodium FOR SOLUTION;ORAL 062321-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 050195-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062856-002 Oct 26, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare BACTOCILL IN PLASTIC CONTAINER oxacillin sodium INJECTABLE;INJECTION 050640-001 Oct 26, 1989 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Renaissance Ssa Llc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 206760-001 Oct 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 201539-001 Jan 18, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon OXACILLIN SODIUM oxacillin sodium CAPSULE;ORAL 061450-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
McKinsey
Citi
McKesson
Express Scripts
UBS
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot